Latest News - Alcon

Monday, March 12, 2018

Alcon Launches National Media Campaign, New Online Tool During World Glaucoma Week

In recognition of World Glaucoma Week, Alcon said it is helping educate people on the world’s leading cause of irreversible blindness and offering new tools that might help improve the lives of …

Read the full story

Friday, March 02, 2018

Alcon Charities Donates nearly $65 Million in Grants and Products in 2017

Alcon directly supported eye health by donating nearly $65 million in cash and products to fund medical missions and community organizations as well as eye exams, glasses, ophthalmic care, and patient…

Read the full story

Thursday, March 01, 2018

Alcon Invests in Multifocal Contact Lens Training, Education and Resources for Eye Care Professionals, Helping Support Patient and Practice Outcomes

In 2018, Alcon is increasing its investment and more than doubling peer-to-peer hands-on multifocal contact lens trainings at its Alcon Experience Center. Alcon will also more than double its Multifoc…

Read the full story

Thursday, March 01, 2018

New Data on the CyPass Micro-Stent Presented at the American Glaucoma Society Meeting

Alcon presented new data from the COMPASS Randomized Controlled Trial that reinforce the clinical value of its CyPass Micro-Stent, a microinvasive glaucoma surgery (MIGS) device implanted at the time …

Read the full story

Friday, December 08, 2017

Alcon Launches New Website

Global eye care company Alcon has this week announced the launch of its new website, with a view to placing opticians ‘at the heart of the journey’. Informed by the brand’s core prin…

Read the full story

Thursday, November 09, 2017

Alcon Introduces Newly Optimized UltraSert Preloaded IOL Delivery System

Alcon introduced the new UltraSert delivery system preloaded with the AcrySof IQ aspheric monofocal IOL at the American Academy of Ophthalmology annual meeting. Data will be presented at AAO on the Ul…

Read the full story

Wednesday, October 11, 2017

New Data Shows Astigmatism Tends to Worsen Following Cataract Surgery With a Standard Monofocal IOL

Alcon presented a real-world data analysis that looks at the impact of not treating astigmatism during cataract surgery, and results from the "More to See" survey that reveal a widespread la…

Read the full story

Tuesday, October 10, 2017

Data Presentations at ESCRS on Astigmatism, CyPass, and AcrySof IOLs

Alcon will present a real-world data analysis that looks at the impact of not treating astigmatism during cataract surgery, and results from the “More to See” survey that reveal a widespre…

Read the full story

Friday, October 06, 2017

Alcon Receives CE Mark for AutonoMe Preloaded IOL Delivery System with Clareon IOL

Alcon has achieved European CE Mark for the Clareon IOL with the AutonoMe delivery system. AutonoMe is the first automated, disposable, preloaded IOL delivery system that enables precise delivery of t…

Read the full story

Monday, October 02, 2017

Alcon to Introduce Clareon IOL, Conduct Several Presentations, at Annual ESCRS Meeting

Alcon will introduce its new monofocal IOL, Clareon, at the European Society of Cataract & Refractive Surgeons (ESCRS) congress taking place October 7-11 in Lisbon, Portugal. In addition, Alcon wi…

Read the full story

Monday, September 25, 2017

Alcon Teams Up With US Olympians Laurie Hernandez and Tobin Heath to Launch the Dailies Invisible Edge Campaign

Alcon is launching a new consumer education campaign called "Invisible Edge" with the help of Olympic gold- and silver-medalist Laurie Hernandez and two-time gold-medalist Tobin Heath. These…

Read the full story

Monday, September 18, 2017

ThromboGenics Regains Global Rights to Jetrea

ThromboGenics announced that it will regain full global rights to Jetrea (ocriplasmin) from Alcon based on a mutual agreement. Under the terms of the agreement, ThromboGenics will receive a cash amoun…

Read the full story

Monday, September 04, 2017

Novartis CEO Joseph Jimenez to Retire Next Year; Vasant Narasimhan Named as Replacement

Novartis announced Monday that CEO Joseph Jimenez will step down from his role effective January 31, 2018, to be replaced by Vasant Narasimhan, the company's current global head of drug developmen…

Read the full story

Thursday, August 31, 2017

Alcon Announces CyPass Micro-Stent’s Unique Procedure Code Becomes Effective, Paving the Way for Medicare Reimbursement

Alcon announced that the unique Current Procedural Terminology (CPT) code 0474T issued by the American Medical Association for the newly launched CyPass Micro-Stent is now effective. The CyPass Micro-…

Read the full story

Tuesday, July 18, 2017

Latest Novartis Earnings Show Signs of a Rebound at Alcon

As part of its second quarter earnings, Novartis reported that sales at its Alcon unit accelerated in the second quarter. Novartis Chief Executive Joe Jimenez said the results increase the number of o…

Read the full story
Load More